ONCOSEC MEDICAL Inc Quarterly Operating Income (Loss) in USD from Q3 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ONCOSEC MEDICAL Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q4 2022.
  • ONCOSEC MEDICAL Inc Operating Income (Loss) for the quarter ending January 31, 2023 was -$7.66M, a 18.6% increase year-over-year.
  • ONCOSEC MEDICAL Inc Operating Income (Loss) for the twelve months ending January 31, 2023 was -$32.7M, a 25.2% increase year-over-year.
  • ONCOSEC MEDICAL Inc annual Operating Income (Loss) for 2022 was -$37M, a 23.5% increase from 2021.
  • ONCOSEC MEDICAL Inc annual Operating Income (Loss) for 2021 was -$48.4M, a 11.5% decline from 2020.
  • ONCOSEC MEDICAL Inc annual Operating Income (Loss) for 2020 was -$43.4M, a 42.7% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$32.7M -$7.66M +$1.75M +18.6% Nov 1, 2022 Jan 31, 2023 10-Q 2023-03-14
Q3 2022 -$34.4M -$7.31M +$2.61M +26.3% Aug 1, 2022 Oct 31, 2022 10-Q 2022-12-15
Q2 2022 -$37M -$8.13M +$5.74M +41.4% May 1, 2022 Jul 31, 2022 10-K 2022-10-31
Q1 2022 -$42.8M -$9.55M +$889K +8.52% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 -$43.6M -$9.42M +$1.61M +14.6% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
Q3 2021 -$45.3M -$9.92M +$3.12M +24% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-15
Q2 2021 -$48.4M -$13.9M -$3.66M -35.9% May 1, 2021 Jul 31, 2021 10-K 2022-10-31
Q1 2021 -$44.7M -$10.4M -$602K -6.12% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 -$44.1M -$11M +$2.5M +18.5% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$46.6M -$13M -$3.2M -32.5% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 -$43.4M -$10.2M -$2.69M -35.8% May 1, 2020 Jul 31, 2020 10-K 2021-10-29
Q1 2020 -$40.7M -$9.83M -$2.92M -42.2% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 -$37.8M -$13.5M -$5.04M -59.5% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 -$32.8M -$9.84M -$2.33M -31.1% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 -$30.4M -$7.52M +$5.08M +40.3% May 1, 2019 Jul 31, 2019 10-K 2020-10-28
Q1 2019 -$35.5M -$6.91M +$2.38M +25.6% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 -$37.9M -$8.48M -$195K -2.35% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 -$37.7M -$7.5M -$1.58M -26.6% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-13
Q2 2018 -$36.1M -$12.6M -$6.7M -114% May 1, 2018 Jul 31, 2018 10-K/A 2019-11-27
Q1 2018 -$29.4M -$9.29M -$4.62M -98.9% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 -$24.8M -$8.29M -$2.86M -52.6% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-08
Q3 2017 -$21.9M -$5.93M -$279K -4.94% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 -$21.6M -$5.9M +$664K +10.1% May 1, 2017 Jul 31, 2017 10-K 2017-10-25
Q1 2017 -$22.3M -$4.67M +$1.58M +25.3% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-13
Q4 2016 -$23.9M -$5.43M +$1.61M +22.8% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-09
Q3 2016 -$25.5M -$5.65M +$1.39M +19.7% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q2 2016 -$26.9M -$6.56M +$14.4K +0.22% May 1, 2016 Jul 31, 2016 10-K 2017-10-25
Q1 2016 -$26.9M -$6.25M -$265K -4.42% Feb 1, 2016 Apr 30, 2016 10-K 2017-10-25
Q4 2015 -$26.6M -$7.04M -$2.42M -52.4% Nov 1, 2015 Jan 31, 2016 10-K 2017-10-25
Q3 2015 -$24.2M -$7.04M -$2.98M -73.3% Aug 1, 2015 Oct 31, 2015 10-K 2017-10-25
Q2 2015 -$21.2M -$6.58M -$3.03M -85.6% May 1, 2015 Jul 31, 2015 10-K 2016-10-13
Q1 2015 -$18.2M -$5.99M -$2.17M -56.9% Feb 1, 2015 Apr 30, 2015 10-K 2016-10-13
Q4 2014 -$16M -$4.62M -$2.02M -77.5% Nov 1, 2014 Jan 31, 2015 10-K 2016-10-13
Q3 2014 -$14M -$4.06M -$2.07M -104% Aug 1, 2014 Oct 31, 2014 10-K 2016-10-13
Q2 2014 -$11.9M -$3.54M -$1.78M -101% May 1, 2014 Jul 31, 2014 10-K 2015-10-14
Q1 2014 -$10.2M -$3.82M -$2.11M -123% Feb 1, 2014 Apr 30, 2014 10-K 2015-10-14
Q4 2013 -$8.06M -$2.6M -$1M -62.8% Nov 1, 2013 Jan 31, 2014 10-K 2015-10-14
Q3 2013 -$7.06M -$1.99M +$8.98K +0.45% Aug 1, 2013 Oct 31, 2013 10-K 2015-10-14
Q2 2013 -$7.06M -$1.76M -$197K -12.6% May 1, 2013 Jul 31, 2013 10-K 2014-10-10
Q1 2013 -$6.87M -$1.71M -$120K -7.57% Feb 1, 2013 Apr 30, 2013 10-K 2014-10-10
Q4 2012 -$6.75M -$1.6M -$418K -35.4% Nov 1, 2012 Jan 31, 2013 10-K 2014-10-10
Q3 2012 -$6.33M -$2M -$803K -67.3% Aug 1, 2012 Oct 31, 2012 10-K 2014-10-10
Q2 2012 -$5.53M -$1.56M -$371K -31.2% May 1, 2012 Jul 31, 2012 10-K 2014-10-10
Q1 2012 -$5.16M -$1.59M -$1.09M -220% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$4.06M -$1.18M -$1.18M Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-15
Q3 2011 -$2.89M -$1.19M -$1.19M Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-17
Q2 2011 -$1.7M -$1.19M May 1, 2011 Jul 31, 2011 10-K 2012-10-15
Q1 2011 -$496K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$4.35K* Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 -$2.45K* Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.